Bharat Enters Chikungunya Fray As Vaccine Moves Into Trials

Indian vaccine developer Bharat Biotech has moved a candidate vaccine for chikungunya into Phase I trials, joining over a dozen firms worldwide hoping to commercialize the first vaccine to halt transmission of the painful mosquito-borne illness, which is spreading globally.

Close-up of a mosquito sucking blood

Privately held Indian vaccine maker Bharat Biotech International Ltd., which already has two candidates in the race to create the world’s first vaccine to protect against the Zika virus, is now hoping to develop a vaccine to prevent the debilitating illness chikungunya.

But the company, based in the southern Indian city of Hyderabad, is up against some stiff competition from over a...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia